Levi C.M. Buil - Concepedia

Concepedia

Author

Levi C.M. Buil

The Netherlands Cancer Institute

Also Known As

Buil, Levi Conrad Maria, L C M Buil, Levi Buil, Levi C M Buil, Levi C. Buil, Levi C. M. Buil, Levi C.M. Buil, Levi Conrad Maria Buil

69

Publications

1.4K

Citations

17

H-Index

27

Concepts

All Affiliations

The Netherlands Cancer Institute Utrecht University Slotervaartziekenhuis Oncode Institute Cancer Genomics Centre

LC

About

Levi C.M. Buil is an author at The Netherlands Cancer Institute specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	416
2	Cell Biology	3	3	372
3	Natural Sciences	1	1	13
4	Biomolecular Engineering	1	1	24
5	Immunology	1	1	13

Levi C.M. Buil

×

19

Publications

1.4K

Citations

17

H-Index

	Year	Citations
Tumour-specific proline vulnerability uncovered by differential ribosome codon reading Fabricio Loayza‐Puch, Koos Rooijers, Levi C.M. Buil, Nature Tumor BiologyTumour-specific Proline VulnerabilityMedicinePathologyProteomics	2016	276
ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy Fan Lin, Mark C. de Gooijer, Eloy Moreno Roig, Clinical Cancer Research	2014	137
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations Kalyan Dulla, Ralph Slijkerman, Hester C. van Diepen, Molecular Therapy	2021	135
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2 Mark C. de Gooijer, Nienke A. de Vries, Tessa Buckle, Neoplasia	2018	125
P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib Mark C. de Gooijer, Ping Zhang, Nishita Thota, Investigational New Drugs Cdk4/6 Inhibitor PalbociclibMedicineReceptor Tyrosine KinaseBrain PenetrationAnti-cancer Agent	2015	83
PI3K–mTOR Pathway Inhibition Exhibits Efficacy Against High-grade Glioma in Clinically Relevant Mouse Models Fan Lin, Mark C. de Gooijer, Diana Hanekamp, Clinical Cancer Research	2016	80
Buparlisib is a brain penetrable pan-PI3K inhibitor Mark C. de Gooijer, Ping Zhang, Levi C.M. Buil, Scientific Reports	2018	80
The impact of P‐glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors Mark C. de Gooijer, Ping Zhang, Ruud Weijer, International Journal of Cancer	2017	70
<scp>ABCB</scp>1 and <scp>ABCG</scp>2 restrict the brain penetration of a panel of novel <scp>EZH</scp>2‐Inhibitors Ping Zhang, Mark C. de Gooijer, Levi C.M. Buil, International Journal of Cancer	2015	67
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma Michaël H. Meel, Mark C. de Gooijer, Dennis S. Metselaar, Clinical Cancer Research	2020	60

Page 1